TENAYA THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.395 USD | -0.11% |
|
-1.55% | +37.04% |
| 20/03 | Canaccord Genuity Adjusts Price Target on Tenaya Therapeutics to $18 From $19, Maintains Buy Rating | MT |
| 19/03 | North American Morning Briefing : Stock Futures -2- | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TENAYA THERAPEUTICS, INC. | Other Biotechnology & Medical Research | +1.02% | -1.55% | +37.04% | -36.57% | - | 35Cr |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- TNYA Stock
- Charts Tenaya Therapeutics, Inc.
- Comparison Chart
